phenothiazine vs (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole
Mechanistic comparison of phenothiazine and (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole [Supplementary Concept] neutral analog of amyloid-binding thioflavin-T (BTA) that crosses based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
15%
Jaccard Similarity
19%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
phenothiazine and (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.154 means 15% of the combined target set is bound by both compounds. The IDF-weighted score of 0.191 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
Related Comparisons
Similar to phenothiazine
Similar to (N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole
(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs lipocrine2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs retinal2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs retinol2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs memoquin2 targets(N-methyl-C-11)-2-(4-methylamino-phenyl)-6-hydroxybenzothiazole vs 2 targets